BE study designs [Design Issues]

posted by nguyenvo – 2006-04-30 23:40 (6933 d 00:54 ago) – Posting: # 98
Views: 27,440

Dear Dr. Helmut,

RP Qu

Sample Size and Power Calculation for High Order Crossover Design

❝ Bio/Pharma Quarterly 9(1), 9-14 (March 2003)

❝ which is available online (277kB PDF).


I am trying to access the link but there is something wrong. It is no longer valid. Could you please check it again?
Thank you for your help.

Best regards,
Nguyen

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,668 registered users;
29 visitors (0 registered, 29 guests [including 0 identified bots]).
Forum time: 00:35 CEST (Europe/Vienna)

The difference between a surrogate and a true endpoint
is like the difference between a cheque and cash.
You can get the cheque earlier but then,
of course, it might bounce.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5